Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers.

Yera-Alos, Isis B

Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers. [electronic resource] - BMC pharmacology & toxicology Sep 2013 - 44 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

2050-6511

10.1186/2050-6511-14-44 doi


Adult
Aged
Aged, 80 and over
Amputation, Surgical--statistics & numerical data
Diabetic Foot--drug therapy
Dose-Response Relationship, Drug
Epidermal Growth Factor--administration & dosage
Female
Granulation Tissue--drug effects
Humans
Injections, Intralesional
Male
Middle Aged
Product Surveillance, Postmarketing
Prospective Studies
Treatment Outcome
Wound Healing--drug effects
Young Adult